Nanexa granted patent in South Korea
Nanexa AB (publ) today announced that the company has been granted a patent in South Korea relating to PharmaShell®-coated drugs.
"Our primary patent has now been granted in the important markets of the USA, Japan, China and South Korea. We continue to strengthen our broad patent protection which is very encouraging,” said David Westberg, CEO of Nanexa.
The patent application for the primary patent for the drug delivery system has also been filed in the European Patent Office, Canada and India.